More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP), a subsidiary of Philip Morris International, joint venture with a Canadian biotech firm focusing on cannabinoid-based drugs – Avicanna. According to the press release, the joint venture seeks to promote cannabis accessibility and research. Avicanna already has a stronghold in the wellness sector. However, the press release hardly makes any other mention about the involvement of Philip Morris International, but it’s clear that Big Tobacco has long had their eye in the cannabis industry.
Cannabis grower and edibles pioneer Maya Elisabeth makes the case that your sourdough starter is…
Berlin police are warning residents after receiving reports that suspected drug samples were being left…
Cannabis culture survived through decentralized human connection. Its future depends on whether the people building…
For years, the cannabis world has treated "the entourage effect" like settled science, a comforting…
After five years, two applications, six figures in expenses, and a maze of shifting rules,…
This article was originally published in 2023. From the hash and honey oil of the…